- Home
- Applications
- usa rhode island
- clinical feasibility study
Refine by
Clinical Feasibility Study Product Applications Available In Usa Rhode Island
60 applications found
Premium
Discover Analytik Jena’s molecular biology and chemical analysis solutions for the pharmaceutical and life science industries. All of the solutions can be automated to a high degree thanks to our extensive liquid handling portfolio. Whether nucleic acid extraction, protein analysis with ICP-MS or various PCR and qPCR/Real-time PCR solutions, early research, or the evaluation in clinical studies, our technologies and methods will increase efficiency of your entire ...
ByAnalytik Jena - an EndressHauser Company based in Jena, GERMANY
Prancer RTSM provides the flexibility you need to explore all the possible paths for determining the optimal dose, patient population, and combination therapies within your Phase 2 ...
By4G Clinical based in Wellesley, MASSACHUSETTS (USA)
We are pleased to offer the opportunity to support research fellowships in a wide array of disciplines (clinical medicine, basic research, epidemiology, pharmacology, nursing). ...
ByModerna, Inc. based in Cambridge, MASSACHUSETTS (USA)
Site satisfaction is a top priority at 4G Clinical. Prancer RTSM® was designed with direct site feedback, ensuring researchers are able to spend more time with their patients and less time worrying about ...
By4G Clinical based in Wellesley, MASSACHUSETTS (USA)
Measuring mRNA transcript abundance with RNASeq methods offers clinical researchers a powerful platform to examine changes in the expression levels of multiple biomarkers. The power of targeted RNASeq lies in its ability to count the number of reads of a given transcript in a sample as a surrogate for expression level, much like a digital PCR system but able to measure 100s of biomarkers simultaneously. A challenge to widespread adoption of RNASeq transcript abundance measurement for clinical studies and ...
ByAccuGenomics, Inc. based in Wilmington, NORTH CAROLINA (USA)
When Otsuka saw a need for clinical expertise and research in the nephrology space, we decided to lead the way. For more than 20 years, we have been bringing our research and expertise to this therapeutic area. We have focused on developing novel drugs in areas of unmet need, such as autosomal dominant polycystic kidney disease and hyponatremia, that have changed the treatment landscape. Our long-term perseverance has led to major breakthroughs, giving patients renewed hope and clinicians more options than ...
ByOtsuka America Pharmaceutical, Inc based in Princeton, NEW JERSEY (USA)
Premium
Environics systems deliver precise gas concentrations for a wide range of clinical and research applications. Tailored to your exact research specifications, the exceptional accuracy makes them the preferred choice for laboratories and research settings requiring reliable and repeatable gas ...
ByEnvironics, Inc. based in Tolland, CONNECTICUT (USA)
We are driven to improve and extend the life of patients suffering from neurological diseases by providing an innovative technology for patients. Our commitment to clinical research is an essential and integral part of our mission and is demonstrated in our clinical trial work. ...
ByMonteris Medical based in Minnetonka, MINNESOTA (USA)
Challenge: Aging is most visible in the face, yet it is the most difficult area of skin assessment. We enable: Personalized skin assessment and individual monitoring of aging in the ...
ByCitus AG based in Dübendorf, SWITZERLAND
Clinical trials are scientific studies, conducted by doctors, to determine how well a new treatment works and if it has any side e?ects in people. The goal is to help people by finding better ways to prevent, screen for, diagnose, or treat disease. People can participate in clinical trials as patients or healthy ...
ByZymeworks Inc based in Vancouver, BRITISH COLUMBIA (CANADA)
Leading the public safety market with publications, websites, conferences and custom publishing, PennWell EMS group serves professionals in EMS worldwide. JEMS (Journal of Emergency Medical Services) and the EMS Today Conference and Exposition are the leading providers of information for the improvement of patient care in the prehospital setting. We achieve our mission by delivering the latest and most reliable information through clinical breakthroughs, compelling case studies, management perspectives, legal ...
ByPennWell Corporation based in Tulsa, OKLAHOMA (USA)
Clinical trials are a critical step in the development process of a new therapeutic like Cellphire’s Thrombosomes®. Before you decide whether to participate in a clinical trial, it is important to have as much information as ...
ByCellphire Therapeutics, Inc. based in Rockville, MARYLAND (USA)
Our work with leading device companies across clinical specialties means we’re uniquely positioned to identify gaps in care and uncover market opportunities. This perspective, combined with our deep device development and manufacturing experience, leads to the conception of whole product solutions, currently focused in neurocritical care. Our partners can leverage these platforms to advance their technologies, or expand their bag of market-ready ...
ByMinnetronix Medical based in St. Paul, MINNESOTA (USA)
A clinical research study is designed to answer questions about the safety and effectiveness of potential new procedures. These studies must be performed before a new procedure can be approved for use in ...
ByFractyl Health based in Lexington, MASSACHUSETTS (USA)
Clinical trials play a critical role in research and in making discoveries in healthcare. It’s these breakthroughs in science that help people defy the limitations of their disease. This would not be possible without the participation of patients, who are at the heart of everything we ...
ByOtsuka America Pharmaceutical, Inc based in Princeton, NEW JERSEY (USA)
Nuubo considers that cutting edge technology can only be considered as such if it also works in real life, with real patients living a normal life. That is why Nuubo is strongly focused on clinical research. Apart from the completed and published studies, Nuubo currently has approximately 3500 patients enrolled in ongoing clinical trials, validating the Nuubo technology for real clinical use. Nuubo is conducting studies in the following ...
ByNuubo based in Edificio Spaces, SPAIN
HIGHLY PREVALENT DISEASE Chronic sinusitis is one of the most prevalent chronic conditions among adults in the U.S. The prevalence rates vary by source from approximately 5%-15% of the adult population. The Centers for Disease Control (CDC) estimates that chronic sinusitis occurs in approximately 12% of the U.S. adult (18 years and older) population. In 2015, there were an estimated 29 million adult chronic sinusitis patients in the U.S. There were approximately six million pediatric chronic sinusitis patients in ...
ByDalent Medical based in Miami, FLORIDA (USA)
Data Ownership and Governance as Leverage for Patient Groups to Accelerate Therapies for their Disease, Jeeva's patent pending eClinical cloud solution for rapid remote touch-less patient enrollment, electronic informed consent, and data collection to setup registries or natural history studies with bi-directional communication and frictionless user experience for coordinators and patients. ...
ByJeeva Informatics Solutions Inc. based in Manassas, VIRGINIA (USA)
The Inspyre™ by SmartMonitor has been evaluated at in-patient clinical studies with leading medical institutions. It has been assessed for its ability to detect and provide an epilepsy medical alert upon certain patterns of abnormal motion. We have successfully collaborated on clinical studies with organizations like Boston Children’s Hospital, John Hopkins Medicine, NYU Langone Medical Center, Stanford School of Medicine, UCSF Medical Center, University of Virginia Health System. The Inspyre™ is ...
BySmart Monitor based in San Jose, CALIFORNIA (USA)
VASCADE MVP Early Ambulation. Simple. Proven: VASCADE MVP enables you to get back on your feet, is simple for doctors to use and is clinically proven, reducing the need for prolonged bedrest associated with manual compression following a procedure that requires access through one or more veins1. In a recent clinical study, VASCADE MVP shortened the median patient bedrest by 64% (3.9 hours), reduced the need for opioids by 58%, and increased patient satisfaction for duration of bedrest by 63%. ...
ByCardival Medical, Inc. based in Santa Clara, CALIFORNIA (USA)